Last Updated: June 27, 2026

Suppliers and packagers for FIRVANQ KIT


✉ Email this page to a colleague

« Back to Dashboard


FIRVANQ KIT

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910 NDA AUTHORIZED GENERIC Wilshire Pharmaceuticals, Inc. 52536-104-05 1 KIT in 1 CARTON (52536-104-05) * 3.75 g in 1 BOTTLE (52536-094-05) * 147 mL in 1 BOTTLE (52536-084-05) 2023-03-31
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910 NDA AUTHORIZED GENERIC Wilshire Pharmaceuticals, Inc. 52536-106-05 1 KIT in 1 CARTON (52536-106-05) * 7.5 g in 1 BOTTLE (52536-096-05) * 145 mL in 1 BOTTLE (52536-086-05) 2023-03-31
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910 NDA AUTHORIZED GENERIC Wilshire Pharmaceuticals, Inc. 52536-107-10 1 KIT in 1 CARTON (52536-107-10) * 295 mL in 1 BOTTLE (52536-085-10) * 7.5 g in 1 BOTTLE (52536-095-10) 2023-03-31
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910 NDA AUTHORIZED GENERIC Wilshire Pharmaceuticals, Inc. 52536-108-10 1 KIT in 1 CARTON (52536-108-10) * 289 mL in 1 BOTTLE (52536-088-10) * 15 g in 1 BOTTLE (52536-098-10) 2023-03-31
Azurity FIRVANQ KIT vancomycin hydrochloride FOR SOLUTION;ORAL 208910 NDA Azurity Pharmaceuticals, Inc 65628-204-05 1 KIT in 1 CARTON (65628-204-05) * 3.75 g in 1 BOTTLE * 147 mL in 1 BOTTLE 2018-01-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for FIRVANQ KIT

Last updated: June 12, 2026

FIRVANQ KIT suppliers: who makes the drug and provides manufacturing, packaging, and distribution?

Executive summary: FIRVANQ KIT is a branded pharmaceutical kit. The manufacturing, packaging, and labeling supply chain is typically split across (1) the active drug substance/formulated drug manufacturer, (2) the kit component manufacturers (drug product components), and (3) the kit assembler/secondary packer and distributor. However, no verified supplier-by-supplier details can be provided from the information available here.

What is FIRVANQ KIT and what suppliers typically make the components?

Direct answer: A “kit” product has multiple components (drug products and/or medical items) assembled under one brand label. Supplier identification requires the FDA product listing (e.g., Orange Book/NDC directory), labeling “Manufactured for/Distributed by” statements, and the kit component manufacturers listed on the FDA label or submission.

Which supplier roles exist in a branded drug kit supply chain?

  • Drug product manufacturer for the active, formulated component(s)
  • Packaging/labeling facility for final kit labeling
  • Kit assembler/secondary packer (often a different site from primary manufacturing)
  • Distributor/marketer on the finished labeled kit

What FDA listings show FIRVANQ KIT’s manufacturer and labeler?

Direct answer: FDA’s NDC and labeling records identify the labeler (usually tied to distribution/market) and sometimes the manufacturing sites. Orange Book data may identify applicants/holders and approvals, but kit component sourcing and site-level suppliers usually require label text or FDA listing details.

How to map FIRVANQ KIT suppliers from NDC labeler and SPL

  • Use the labeler name as the starting point for the public-facing supplier
  • Use label text such as “Manufactured by,” “Manufactured for,” or “Distributed by”
  • Cross-check with facility identifiers in FDA listings to isolate actual manufacturing sites

What manufacturers are listed on the FIRVANQ KIT label?

Direct answer: Supplier names are printed on the kit’s prescribing information and carton labels, commonly in the form of manufactured for, manufactured by, and distributed by lines. Those label text lines are the primary source for named suppliers.

How FIRVANQ KIT suppliers are usually presented on packaging

  • Kit carton: company and site for packaging/labeling
  • Insert: manufacturer of the drug product(s) and the applicant/holder

Which companies supply FIRVANQ KIT globally (US vs. other markets)?

Direct answer: Global supplier geography depends on regional marketing authorizations and local labeling/distribution arrangements. Without verified region-specific label/SPL records, supplier identification cannot be stated.

Why “same manufacturer” is not guaranteed across jurisdictions

  • Local labeler/distributor changes
  • Packaging and secondary assembly often moves to regional partners
  • GMP site authorizations differ by regulator

What distributors supply FIRVANQ KIT to pharmacies and hospitals?

Direct answer: Distribution depends on the labeled market authorization holder and commercial distribution partners listed on the label, plus wholesaler/3PL network contracts. Named distributors are typically not consistent across channels unless explicitly identified on label or in regulatory filings.

Typical distribution chain in the US for branded kits

  • Manufacturer or packer supplies to
  • Labeler/marketer or appointed logistics provider
  • Wholesalers or hospital GPO distribution
  • Pharmacy/hospital dispensing

Does FIRVANQ KIT have a specific kit assembler supplier?

Direct answer: Many kit products use a dedicated secondary packer/kit assembler site. That supplier is usually indicated on the carton/label text tied to final assembly and labeling.

Kit assembly supplier patterns

  • Primary drug product manufactured at one site
  • Kit assembled at another site
  • Final labeled kit distributed from the labeler’s network

Key Takeaways

  • FIRVANQ KIT supplier identification requires verified label/FDA listing text that names the manufactured by/manufactured for/distributed by parties.
  • A kit’s supply chain usually splits into drug product manufacturing, kit assembly/secondary packaging, and distribution/labeling.
  • No supplier-by-supplier facts for FIRVANQ KIT can be stated from the information provided in this session.

FAQs

  1. How can I identify the kit assembler for FIRVANQ KIT?
    From the kit carton and labeling text that states who assembled/packaged the finished kit.

  2. Is the FIRVANQ KIT labeler the same as the manufacturer?
    Often not; the labeler is frequently the marketer/distributor while manufacturing can be at a different GMP site.

  3. What FDA resource shows FIRVANQ KIT’s labeler name?
    FDA NDC directory and the SPL/labeling records linked to the product’s NDC.

  4. Do FIRVANQ KIT component suppliers differ from the finished kit supplier?
    Commonly yes, because kits combine multiple component products sourced from different manufacturers.

  5. How do I find FIRVANQ KIT manufacturing sites from public data?
    By matching label “manufacturing/packaging” statements and facility identifiers in FDA listing/SPL documents.

References

  1. FDA. Orange Book: Approved Drug Products With Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
  2. FDA. NDC Directory (Structured Product Labeling and NDC listing data). U.S. Food and Drug Administration.
  3. FDA. SPL (Structured Product Labeling) data for drug products and labeling records. U.S. Food and Drug Administration.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.